G Spahn

407 total citations
13 papers, 296 citations indexed

About

G Spahn is a scholar working on Complementary and alternative medicine, Surgery and Molecular Biology. According to data from OpenAlex, G Spahn has authored 13 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Complementary and alternative medicine, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in G Spahn's work include Complementary and Alternative Medicine Studies (6 papers), Dermatology and Skin Diseases (2 papers) and Herbal Medicine Research Studies (2 papers). G Spahn is often cited by papers focused on Complementary and Alternative Medicine Studies (6 papers), Dermatology and Skin Diseases (2 papers) and Herbal Medicine Research Studies (2 papers). G Spahn collaborates with scholars based in Germany, Austria and Switzerland. G Spahn's co-authors include Jost Langhorst, Andreas Michalsen, Gustav Dobos, Ulf Steder-Neukamm, Andreas Rueffer, Sigrid Elsenbruch, Gustav Dobos, Rainer Lüdtke, Rainer Luedtke and S. Baron and has published in prestigious journals such as Experimental Biology and Medicine, Inflammatory Bowel Diseases and Complementary Therapies in Medicine.

In The Last Decade

G Spahn

10 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Spahn Germany 5 156 82 77 70 47 13 296
Raphael P. Luber Australia 10 166 1.1× 85 1.0× 38 0.5× 50 0.7× 37 0.8× 27 344
Jocelyn Fraser United Kingdom 7 94 0.6× 102 1.2× 113 1.5× 68 1.0× 146 3.1× 9 351
Evelina Suraci Italy 13 131 0.8× 134 1.6× 19 0.2× 193 2.8× 112 2.4× 30 493
Ulf Steder-Neukamm Germany 9 202 1.3× 185 2.3× 80 1.0× 64 0.9× 57 1.2× 9 366
Caroline T. Brown United States 5 135 0.9× 72 0.9× 10 0.1× 53 0.8× 16 0.3× 11 347
Mariantonia Lai Italy 10 107 0.7× 142 1.7× 12 0.2× 138 2.0× 172 3.7× 17 338
Gioia Persuitte United States 8 123 0.8× 45 0.5× 6 0.1× 58 0.8× 57 1.2× 12 320
Bryce K. Perler United States 5 65 0.4× 88 1.1× 10 0.1× 58 0.8× 61 1.3× 8 359
Virginie Chotard Canada 2 257 1.6× 162 2.0× 6 0.1× 112 1.6× 44 0.9× 5 353
Sabina Więcek Poland 13 129 0.8× 82 1.0× 5 0.1× 140 2.0× 66 1.4× 54 380

Countries citing papers authored by G Spahn

Since Specialization
Citations

This map shows the geographic impact of G Spahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Spahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Spahn more than expected).

Fields of papers citing papers by G Spahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Spahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Spahn. The network helps show where G Spahn may publish in the future.

Co-authorship network of co-authors of G Spahn

This figure shows the co-authorship network connecting the top 25 collaborators of G Spahn. A scholar is included among the top collaborators of G Spahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Spahn. G Spahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gantz, Simone, Silvia Schneider, Marcus Schiltenwolf, et al.. (2012). Laufsport. Trauma und Berufskrankheit. 14(S4). 446–451. 1 indexed citations
2.
Hübner, Jutta & G Spahn. (2009). Sekundäre Pflanzenstoffe. Der Onkologe. 15(11). 1144–1150. 1 indexed citations
3.
Spahn, G, et al.. (2007). Gruppeninterventionsprogramme in der Onkologie. Der Onkologe. 13(6). 520–527.
4.
Spahn, G, et al.. (2007). Untersuchung zur Bestimmung von krankheitsassoziierten Faktoren der Gonarthrose. Physikalische Medizin Rehabilitationsmedizin Kurortmedizin. 17(5). 253–259. 2 indexed citations
5.
Langhorst, Jost, Ulf Steder-Neukamm, Rainer Luedtke, et al.. (2006). Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: Perceived stress is a potential indicator for CAM use. Complementary Therapies in Medicine. 15(1). 30–37. 43 indexed citations
6.
Langhorst, Jost, Ulf Steder-Neukamm, Rainer Lüdtke, et al.. (2005). Amount of Systemic Steroid Medication Is a Strong Predictor for the Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease.. Inflammatory Bowel Diseases. 11(3). 287–295. 91 indexed citations
7.
Langhorst, Jost, Sigrid Elsenbruch, Andreas Rueffer, et al.. (2005). Comparison of 4 Neutrophil-Derived Proteins in Feces As Indicators of Disease Activity in Ulcerative Colitis. Inflammatory Bowel Diseases. 11(12). 1085–1091. 126 indexed citations
8.
9.
Spahn, G, et al.. (2003). Improvement of fatigue and role function of cancer patients after an outpatient integrative mind/body intervention. Focus on Alternative and Complementary Therapies. 8(4). 540–540. 8 indexed citations
10.
Spahn, G, et al.. (2003). Characteristics of German cancer patients using CAM: a survey in 441 cancer patients. Focus on Alternative and Complementary Therapies. 8(4). 540–541. 1 indexed citations
11.
Kober, G., et al.. (1974). [Width and cross section of epicardial coronary arteries in relation to myocardial hypertrophy].. PubMed. 63(4). 297–310. 3 indexed citations
12.
Kober, G., et al.. (1972). [Width of the large coronary arteries in myocardial hypertrophy using selective arteriography].. PubMed. 38. 191–4. 2 indexed citations
13.
Gazdar, Adi F., A D Steinberg, G Spahn, & S. Baron. (1972). Interferon Inducers: Enhancement of Viral Oncogenesis in Mice and Rats. Experimental Biology and Medicine. 139(4). 1132–1137. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026